Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 10:49 PM
Study NCT ID:
NCT04523467
Status:
UNKNOWN
Last Update Posted:
2020-08-21
First Post:
2020-08-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma
Sponsor:
Eastern Hepatobiliary Surgery Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-18
First Submit QC Date:
None
Study First Post Date:
2020-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-19
Last Update Post Date:
2020-08-21
Last Update Post Date Type:
ACTUAL